SNPX Message Board Post 9839820 | Synaptogenix Inc.
home / stock / snpx / snpx message board
MJR4826
(investorshub)
Posted on: Mar/07/2023 14:04:40
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171377933
Synaptogenix Provides Corporate Update and Outlines Potential Business Oppor
News, Short Squeeze, Breakout and More Instantly...
-
Synaptogenix Announces FDA Authorization of IND Application for Clinical Trial for Bryostatin-1 in Multiple Sclerosis PR Newswire Collaborative study will evaluate drug's potential to improve synaptic health and cognitive function in MS patients NEW YORK , ...
-
Synaptogenix Applauds DEA Proposal to Reclassify Cannabis and Shares Expected Benefits to Cannasoul for Cannabinoid-Based Drug Discovery PR Newswire Proposed Schedule III drug classification expected to de-risk Cannasoul's cannabis research and potential regulatory pathways ...